Factors contributing to the lack of human immunodeficiency virus type 1 (HIV-1) transmission in HIV-1-discordant partners

被引:42
作者
Bienzle, D
MacDonald, KS
Smaill, FM
Kovacs, C
Baqi, M
Courssaris, B
Luscher, MA
Walmsley, SL
Rosenthal, KL
机构
[1] McMaster Univ, Hlth Sci Ctr, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada
[2] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[3] Univ Toronto, Dept Med, Toronto, ON, Canada
[4] Toronto Hosp, Toronto, ON M5T 2S8, Canada
基金
英国医学研究理事会;
关键词
D O I
10.1086/315670
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Correlates of resistance to infection by human immunodeficiency virus type 1 (HIV-I) are important for defining potential therapeutic interventions and for prophylactic vaccination. In this study, Ii couples discordant in their HIV-1 infection status were prospectively evaluated for the presence of protective factors. Behavioral characteristics of all subjects entailed a high risk of transmission, Cytotoxic T lymphocyte (CTL) responses against viruses isolated from the infected partner, and against laboratory virus isolates, were detected in 5 (45%) of ii HIV-negative partners, including a CCR5 Delta 32-homozygous and a heterozygous subject. No CTL responses were observed in 6 control unexposed subjects. Marked variation in lymphocyte susceptibility to viral infection was noted, Resistance attributable to major histocompatibility complex discordance or anti-major histocompatibility complex antibodies was not identified. These results suggest that a combination of factors, including cellular immunity, viral characteristics, and coreceptor integrity, may be involved in the persistent nontransmission of HIV.
引用
收藏
页码:123 / 132
页数:10
相关论文
共 59 条
  • [1] CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1
    Alkhatib, G
    Combadiere, C
    Broder, CC
    Feng, Y
    Kennedy, PE
    Murphy, PM
    Berger, EA
    [J]. SCIENCE, 1996, 272 (5270) : 1955 - 1958
  • [2] [Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
  • [3] CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES
    ARTHUR, LO
    BESS, JW
    SOWDER, RC
    BENVENISTE, RE
    MANN, DL
    CHERMANN, JC
    HENDERSON, LE
    [J]. SCIENCE, 1992, 258 (5090) : 1935 - 1938
  • [4] Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope
    Beretta, A
    Weiss, SH
    Rappocciolo, G
    Mayur, R
    DeSantis, C
    Quirinale, J
    Cosma, A
    Robbioni, P
    Shearer, GM
    Berzofsky, JA
    Villa, ML
    Siccardi, AG
    Clerici, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (02) : 472 - 476
  • [5] Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons
    Bernard, NF
    Yannakis, CM
    Lee, JS
    Tsoukas, CM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (03) : 538 - 547
  • [6] HIV-1 infection in an individual homozygous for the CCR5 deletion allele
    Biti, R
    French, RF
    Young, J
    Bennetts, B
    Stewart, G
    Liang, T
    [J]. NATURE MEDICINE, 1997, 3 (03) : 252 - 253
  • [7] Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)
    Bunce, M
    ONeill, CM
    Barnardo, MCNM
    Krausa, P
    Browning, MJ
    Morris, PJ
    Welsh, KI
    [J]. TISSUE ANTIGENS, 1995, 46 (05): : 355 - 367
  • [8] COMPARISON OF INDIRECT IMMUNOFLUORESCENCE AND WESTERN-BLOT FOR DETECTION OF ANTI-HUMAN IMMUNODEFICIENCY VIRUS-ANTIBODIES
    CARLSON, JR
    YEE, J
    HINRICHS, SH
    BRYANT, ML
    GARDNER, MB
    PEDERSEN, NC
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (03) : 494 - 497
  • [9] HLA and HIV-1:: Heterozygote advantage and B*35-Cw*04 disadvantage
    Carrington, M
    Nelson, GW
    Martin, MP
    Kissner, T
    Vlahov, D
    Goedert, JJ
    Kaslow, R
    Buchbinder, S
    Hoots, K
    O'Brien, SJ
    [J]. SCIENCE, 1999, 283 (5408) : 1748 - 1752
  • [10] PROTECTION IN SIMIAN IMMUNODEFICIENCY VIRUS VACCINATED MONKEYS CORRELATES WITH ANTI-HLA CLASS-I ANTIBODY-RESPONSE
    CHAN, WL
    RODGERS, A
    HANCOCK, RD
    TAFFS, F
    KITCHIN, P
    FARRAR, G
    LIEW, FY
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) : 1203 - 1207